Interview with Antonin Morillon, new unit director

Antonin Morillon, a researcher in epigenetic, in his lab at the Curie Institute. Paris, France. August 18, 2017. 
Antonin Morillon, chercheur en epigenetique, dans son laboratoire a l'Institut Curie. Paris, France. 18 aout 2017.

On 1st January 2019, the management of UMR3244 Genetic Information Dynamics changed. Arturo Londono is handing over the role of unit director to the team leader Antonin Morillon. Interview and Background.

  • Why did you apply for this management position?
    Managing a research institute means widening one’s field of knowledge while helping to bring out and consolidate the research of other teams in the unit. For me, it was the obvious next step to play a role in the strategy and scientific vision of a research team and for this reason, I accepted to take over the excellent work of my predecessor in this position, Arturo Londono.
  • What is your vision for Institut Curie?
    I believe that Institut Curie is the best place in France for conducting research, with an ideal environment in terms of leading-edge technology, exchange of fundamental scientific ideas and also medically viable ideas, with my colleagues in the research center and the hospital.
  • Can you imagine forging ties with the Hospital Group, with translational research (Curie model)?
    I do indeed imagine strengthening our already strong ties with the translational department jointly hosting a SIRIC team (Celine Vallot) and incorporating several collaborations within the PMS (Anne Vincent-Salomon, Y. Allory among others).
  • Does this new position mean new projects for you or is it more of a continuity?
    Continuity in my team projects but also new projects for the unit, in particular with the goal of strengthening and developing artificial intelligence approaches to understanding OMIC data in clinical single cell.

At the end of his term, Arturo Londono looked back on the unit’s primary achievements, of which everyone can be proud:
“During my term, we faced considerable challenges, both from the scientific point of view, with a major change of direction to definitively include bio-informatics in our research, and from an administrative point of view with the renewal of half of our research teams. The result of the HCERES assessment shows that we have lived up to the challenge. Antonin Morillon’s term will transform the try!”
During his term, Antonin Morillon will continue to lead his team Non-Coding RNA, Epigenetic and Genome Fluidity. “My team’s research activity lies in two directions. One is fundamental, using model systems to study non-coding RNA to discover the role they play in maintaining the genome and in genetic instability. The other direction is more translational to identify new tumor biomarkers and new treatment targets.”